Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 734
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03750760 | Early Alirocumab to Reduce LDL-C in Myocardial Infarction | ||
| NCT01363440 | Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema | ||
| NCT03399786 | Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia | ||
| NCT01448317 | Ascending Dose Study of the Safety and Tolerability of Alirocumab (SAR236553/REGN727) in Japanese Healthy Volunteers | ||
| NCT01870427 | NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions | ||
| NCT05608291 | A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery | ||
| NCT04400318 | The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma | ||
| NCT02326220 | Study of Alirocumab (REGN727/SAR236553) in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) Undergoing Low-density Lipoprotein (LDL) Apheresis Therapy | ||
| NCT06191315 | Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS) | ||
| NCT05831176 | A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have | ||
| NCT04447417 | Dupilumab Skin Barrier Function Study in Atopic Dermatitis | ||
| NCT07220785 | Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy | ||
| NCT06826768 | A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC | ||
| NCT05729139 | Cemiplimab/Peg-Interferon-α in Advanced CSCC | ||
| NCT01271972 | Study of Nesvacumab (REGN910/ SAR307746) | ||
| NCT05788536 | A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants With Hearing Loss Due to Otoferlin Mutations | ||
| NCT04101721 | Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity | ||
| NCT00944892 | A Study of the Safety and Efficacy of REGN475(SAR164877) in Patients With Osteoarthritis of the Knee | ||
| NCT01670734 | Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy Subjects | ||
| NCT03146416 | Study of Evinacumab (REGN1500) in Caucasian and in Japanese Healthy Volunteers | ||
| NCT04888507 | Pozelimab and Cemdisiran Combination Therapy in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Who Switch From Eculizumab Therapy | ||
| NCT01997164 | Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular ("Wet") Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME) | ||
| NCT01074372 | Ascending Dose Study of the Safety and Tolerability of REGN727 (SAR236553) in Healthy Volunteers | ||
| NCT05864144 | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors | ||
| NCT02265952 | Study of REGN1500 in Participants With Homozygous Familial Hypercholesterolemia (HoFH) | ||
| NCT01209793 | Safety and Tolerability Study of REGN846 (SAR302352) in Healthy Volunteers | ||
| NCT02023879 | Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II) | ||
| NCT02279537 | Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMD | ||
| NCT05352672 | Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma | ||
| NCT04417894 | A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT) | ||
| NCT04722523 | A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer | ||
| NCT05376553 | Study of Cemiplimab - TP Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck | ||
| NCT03115996 | Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN3918 in Healthy Volunteers | ||
| NCT07318610 | Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease | ||
| NCT04126317 | Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration | ||
| NCT06384820 | Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC) | ||
| NCT03449758 | Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis | ||
| NCT03002376 | An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1) | ||
| NCT07217535 | Rutgers University Study of the Genetics of Kidney Disease | ||
| NCT05478824 | IL13 Signaling in Allergic Asthma | ||
| NCT04287608 | Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic Dermatitis | ||
| NCT04456673 | Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation | ||
| NCT06190951 | A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma | ||
| NCT04992273 | COVID-19 Administration of Single-Dose Subcutaneous Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of Age | ||
| NCT03889912 | Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma | ||
| NCT06465329 | A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT07230834 | Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants | ||
| NCT04940364 | A Study to Examine the Safety, Tolerability and Biological Effects of Single Doses of Subcutaneously and Intravenously Administered Pozelimab as Monotherapy and in Combination With Single Doses of Subcutaneously Administered Cemdisiran in Adult Japanese Healthy Volunteers | ||
| NCT05961709 | The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer | ||
| NCT00083213 | Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma |
